相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids
Jinxin Liu et al.
PHARMACOLOGICAL RESEARCH (2020)
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Tiangang Li et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor
Dong Renchan et al.
PHYTOMEDICINE (2019)
FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury
Bo Kong et al.
DIGESTIVE AND LIVER DISEASE (2019)
Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner
Renchao Dong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review
Meng Wang et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver disease
Shuang Hu et al.
PHARMACOLOGICAL RESEARCH (2019)
Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
Lingli Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Oroxylin A inhibits ethanol-induced hepatocyte senescence viaYAP pathway
Huanhuan Jin et al.
CELL PROLIFERATION (2018)
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
Phillipp Hartmann et al.
HEPATOLOGY (2018)
The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava
C. Michael White
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
Xiaoguang Gao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
Kavita Jadhav et al.
MOLECULAR METABOLISM (2018)
Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver
Tao Zeng et al.
REDOX BIOLOGY (2018)
FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice
Arvin Iracheta-Vellve et al.
HEPATOLOGY COMMUNICATIONS (2018)
Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
Felix Stickel et al.
GUT AND LIVER (2017)
Protective effect of polysaccharide from maca (Lepidium meyenii) on Hep-G2 cells and alcoholic liver oxidative injury in mice
Lijun Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Bile acids and colon cancer: Is FXR the solution of the conundrum?
Raffaella Maria Gadaleta et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
TZAP: A telomere-associated protein involved in telomere length control
Julia Su Zhou Li et al.
SCIENCE (2017)
Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
Yimeng Zhang et al.
TOXICOLOGY (2017)
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Sukhpreet Singh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
Ying Wan et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway
Zhongbo Liu et al.
JOURNAL OF BIOMEDICAL RESEARCH (2017)
Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation
Delia Blaya et al.
GUT (2016)
Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway
Ting Bai et al.
PHARMACOLOGICAL RESEARCH (2016)
Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes
Chunfeng Lu et al.
IUBMB LIFE (2015)
Alcoholic liver disease: mechanisms of injury and targeted treatment
Alexandre Louvet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis
Qiang Meng et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents
Jun Wang et al.
JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE (2015)
Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease
Cosmin S. Voican et al.
LIVER INTERNATIONAL (2015)
Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
Weibin Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
A Comprehensive Model for the Recognition of Human Telomeres by TRF1
Michael Garton et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand
Alessia Ligresti et al.
PHARMACOLOGICAL RESEARCH (2012)
Redox Signaling and the Innate Immune System in Alcoholic Liver Disease
Jessica I. Cohen et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The Protein Network Surrounding the Human Telomere Repeat Binding Factors TRF1, TRF2, and POT1
Richard J. Giannone et al.
PLOS ONE (2010)
Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation
Christoph J. Wruck et al.
MOLECULAR PHARMACOLOGY (2008)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
分享论文
